The DoctorUnion kiosk supplied by UBcare. /Courtesy of UBcare

Digital Healthcare platform corporations UBcare said on the 2nd that operating profit on a consolidation basis last year rose about 45.7% from a year earlier to 7.5 billion won. Revenue for the same period increased about 3.7% to 197.7 billion won.

UBcare is a subsidiary acquired by GC Biopharma Group in 2020 and supplies electronic medical record (EMR) systems to hospitals, clinics, and pharmacies nationwide.

The company said it strengthened core competitiveness and improved its revenue structure last year, centered on its hospital, clinic, and pharmacy businesses. In the hospital and clinic institutional sector, profit expanded more than 50% from a year earlier through adjustments to the profitability of consignment services and greater efficiency in agency operations. The pharmacy institutional sector also maintained a stable profit-generation structure by increasing the number of prescription dispensing cases and pursuing a high–value added strategy for its flagship service, "U-PHARM."

UBcare management recently bought treasury shares in succession. Chief Executive Kim Jin-tae increased holdings to about 79,000 shares through on-market purchases, and key executives including Director Kwon Tae-hoon, Director Baek Seong-hwan, and Director Kim Jun-hyeok also moved to expand their equity. The company said the decision was aimed at resolving undervaluation of corporations value and reinforcing responsible management.

UBcare is targeting an improvement of more than 80% in operating profit this year from a year earlier. While strengthening the profitability of its existing EMR (electronic medical record) business, it plans to officially unveil an artificial intelligence (AI)–based medical support solution in the first half.

A company official said, "We expect it to go beyond simple technological advancement and become a key tool that creates added value for medical staff," and added, "Upon commercialization, we will create a clear turning point for a rebound in results."

An UBcare official said, "We confirmed solid growth through improvements in the revenue structure last year," and added, "This year, we will create a turning point for a rebound in results by strengthening the competitiveness of our core businesses and establishing new services."

※ This article has been translated by AI. Share your feedback here.